Senior Consultant
Current
Jun 2020 - Present
AeroLeads people directory · profile
Max Fehlmann Email & Phone Number
Senior Consultant
at
Theodorus Investment Funds
1 work email found
@neomed.ca
LinkedIn matched
✓ Verified Jun 2026
4 data sources
Profile completeness 100%
Current company
Role
Senior Consultant
Location
Montreal, Quebec, Canada
Company size
Who is Max Fehlmann? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Max Fehlmann is listed as Senior Consultant at Theodorus Investment Funds, a company with 15 employees, based in Montreal, Quebec, Canada. AeroLeads shows a work email signal at neomed.ca and a matched LinkedIn profile for Max Fehlmann.
Max Fehlmann previously worked as Project Director of the Innovation Zone "Artificial Intelligence in Health" at Montréal Invivo and President and Scientific Director at Institut De Recherches Cliniques De Montréal (Ircm) / Montreal Clinical Research Institute. Max Fehlmann holds Master Of Business Administration - Mba, Business Administration And Management, General from Université Nice Sophia Antipolis.
Company email context
Email format at Theodorus Investment Funds
This section adds company-level context without repeating Max Fehlmann's masked contact details.
{first_initial}{last}@neomed.ca
86% confidence
AeroLeads found 1 current-domain work email signal for Max Fehlmann. Compare company email patterns before reaching out.
Profile bio
About Max Fehlmann
Max Fehlmann is a Senior Consultant at Theodorus Investment Funds. He possess expertise in drug discovery, biotechnology, clinical development, lifesciences, strategy and 30 more skills.
Listed skills include Drug Discovery, Biotechnology, Clinical Development, Lifesciences, and 31 others.
Current workplace
Max Fehlmann's current company
Company context helps verify the profile and gives searchers a useful next step.
Theodorus Investment Funds
16 roles · 48 years
Max Fehlmann work experience
A career timeline built from the work history available for this profile.
Project Director Of The Innovation Zone "Artificial Intelligence In Health"
I am in charge of a project to create an Innovation Zone in Montreal focused on Artificial Intelligence (AI) in health. This project, carried out jointly by Montreal InVivo and Montreal International, aims to mobilize all of the health AI players in Greater Montreal to accelerate the development and commercialization of innovations in AI applied to health.
Aug 2021 - Feb 2022
President And Scientific Director
Founded in 1967, the Montreal Clinical Research Institute (IRCM) is a non-profit organization that conducts fundamental and clinical biomedical research in addition to training high-level young scientists in an innovative technological environment. The Institute brings together about 450 people as well as 35 laboratories, which work in cancer, immunology.
Mar 2019 - Jun 2021
President And Ceo
Max has joined the Cancer Research Society as President and CEO in January 2017. Founded in 1945, the Cancer Research Society is the first Canadian foundation entirely dedicated to funding research on all types of cancer. Over the course of its history, the CRS has supported thousands of our country's best scientific minds who have helped make important.
Jan 2017 - Feb 2019
Founder And Ceo
NEOMED-LABS, a Canadian specialty company providing customized and high-throughput immune-monitoring for clinical vaccine and biologics development, is a spin-off from the GSK. Fully owned by the NEOMED Institute the facility is equipped with the latest platform technologies to conduct cutting-edge analyses of host responses to vaccines under GCLP.
Apr 2015 - Jan 2017
Ceo
Neomed Institute
Max founded NEOMED in November 2012 as a not‐for‐profit organization whose mission is to bridge the gap between basic research and the commercialization of new drugs by providing industrial expertise in drug discovery and development, combined with the creation of a vibrant and sustainable life science ecosystem. NEOMED operates two fully integrated.
Nov 2012 - Jan 2017
Founder And Ceo
Founded in 2008 CQDM is a not-for-profit pharma-based consortium active in biopharmaceutical research whose mission is to fund the development of innovative tools and technologies to accelerate drug discovery. Unique in the world, CQDM’s business model is based on a collaborative approach where all stakeholders share the costs of biopharmaceutical research.
May 2008 - Nov 2012
Ceo
Chronogen, Inc., a biotechnology company, researched and developed therapeutics to fight oxidative-stress disorders in age-related diseases. It provided inhibitors for neurodegenerative diseases and atherosclerosis, compounds with cellular oxidative stress modulator activities, compounds for the treatment of pulmonary, hepatic, and renal fibrosis and.
2004 - 2007
~3 yrs
Vp R&D
Vice-President R&D for Zambon Group in Italy responsible for all pre-clinical, clinical, and licensing activities of the group worldwide Founder of Z-cube, a corporate venture fund linked to Zambon Group.
1996 - 2003
~7 yrs
Professor, Director Of The Master Of Pharmacology
1994 - 1996
~2 yrs
Founder And Ceo
Aster Biotechnologies
A start-up company, spun-off from INSERM developing immuno- tools and services for the Pharmaceutical Industry. Aster was specialized in Reproductive Biology, Immunochemistry and Molecular Biology.
1989 - 1996
~7 yrs
1986 - 1989
~3 yrs
1978 - 1989
~11 yrs
1983 - 1986
~3 yrs
1978 - 1983
~5 yrs
Visiting Scientist
1982 - 1983
~1 yr
3 education records
Max Fehlmann education
Master Of Business Administration - Mba, Business Administration And Management, General
Doctor Of Philosophy - Phd, Biochemistry And Molecular Biology
Doctor Of Philosophy - Phd, Biochemistry And Molecular Biology
FAQ
Frequently asked questions about Max Fehlmann
Quick answers generated from the profile data available on this page.
What company does Max Fehlmann work for?
Max Fehlmann works for Theodorus Investment Funds.
What is Max Fehlmann's role at Theodorus Investment Funds?
Max Fehlmann is listed as Senior Consultant at Theodorus Investment Funds.
What is Max Fehlmann's email address?
AeroLeads has found 1 work email signal at @neomed.ca for Max Fehlmann at Theodorus Investment Funds.
Where is Max Fehlmann based?
Max Fehlmann is based in Montreal, Quebec, Canada while working with Theodorus Investment Funds.
What companies has Max Fehlmann worked for?
Max Fehlmann has worked for Theodorus Investment Funds, Montréal Invivo, Institut De Recherches Cliniques De Montréal (Ircm) / Montreal Clinical Research Institute, Cancer Research Society, and Neomed-Labs.
Who are Max Fehlmann's colleagues at Theodorus Investment Funds?
Max Fehlmann's colleagues at Theodorus Investment Funds include Alexandre Franco.
How can I contact Max Fehlmann?
You can use AeroLeads to view verified contact signals for Max Fehlmann at Theodorus Investment Funds, including work email, phone, and LinkedIn data when available.
What schools did Max Fehlmann attend?
Max Fehlmann holds Master Of Business Administration - Mba, Business Administration And Management, General from Université Nice Sophia Antipolis.
What skills is Max Fehlmann known for?
Max Fehlmann is listed with skills including Drug Discovery, Biotechnology, Clinical Development, Lifesciences, Strategy, Pharmaceutical Industry, R&D, and Biochemistry.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trialPeople with similar names
Check these profiles if this is not the Max Fehlmann you were looking for.
Max Fehlmann
1 email domain
